Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response
Abstract Objective Immune checkpoint inhibitors (ICIs) have become the standard of care in various cancers, although the predictive tool is still unknown. Methods This study aimed to develop a novel gene panel by selecting DNA damage response (DDR) genes from the Catalogue of Somatic Mutations in Ca...
Main Authors: | Yi‐Ru Pan, Chiao‐En Wu, Yu‐Chao Wang, Yi‐Chen Yeh, Meng‐Lun Lu, Yi‐Ping Hung, Yee Chao, Da‐Wei Yeh, Chien‐Hsing Lin, Jason Chia‐Hsun Hsieh, Ming‐Huang Chen, Chun‐Nan Yeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Clinical & Translational Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1002/cti2.1145 |
Similar Items
-
Role of the Checkpoint Clamp in DNA Damage Response
by: Mihoko Kai
Published: (2013-01-01) -
DNA Damage Repair Gene Set as a Potential Biomarker for Stratifying Patients with High Tumor Mutational Burden
by: To-Yuan Chiu, et al.
Published: (2021-06-01) -
Function of Replication Protein A in DNA repair and cell checkpoints
by: Hass, Cathy Staloch
Published: (2012) -
Novel Aspects to the Role of Rad9A During the DNA Damage Response
by: Sierant, Megan
Published: (2010) -
Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors
by: Yu Chen, et al.
Published: (2020-09-01)